Atopic dermatitis epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} | ||
==Overview== | ==Overview== | ||
It now affects 10-20% of children and 1-3% of adults in industrialized countries, and its prevalence there has more than doubled in the past thirty years.<ref name=saito>Saito, Hirohisa. Much Atopy about the Skin: Genome-Wide Molecular Analysis of Atopic Eczema. International Archives of Allergy and Immunology 2005;137:319-325.</ref> | It now affects 10-20% of children and 1-3% of adults in industrialized countries, and its prevalence there has more than doubled in the past thirty years.<ref name="saito">Saito, Hirohisa. Much Atopy about the Skin: Genome-Wide Molecular Analysis of Atopic Eczema. International Archives of Allergy and Immunology 2005;137:319-325.</ref> | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
| Line 12: | Line 12: | ||
===Prevalence=== | ===Prevalence=== | ||
*The | *The prevalence of atopic dermatitis is approximately 5,000-20,000 per 100,000 children worldwide.<ref name="pmid9893196">{{cite journal |vauthors=Williams H, Robertson C, Stewart A, Aït-Khaled N, Anabwani G, Anderson R, Asher I, Beasley R, Björkstén B, Burr M, Clayton T, Crane J, Ellwood P, Keil U, Lai C, Mallol J, Martinez F, Mitchell E, Montefort S, Pearce N, Shah J, Sibbald B, Strachan D, von Mutius E, Weiland SK |title=Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood |journal=J. Allergy Clin. Immunol. |volume=103 |issue=1 Pt 1 |pages=125–38 |date=January 1999 |pmid=9893196 |doi= |url=}}</ref> | ||
*The prevalence of atopic dermatitis is approximately 10700 per 100,000 children in United States.<ref name="pmid20739951">{{cite journal |vauthors=Shaw TE, Currie GP, Koudelka CW, Simpson EL |title=Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health |journal=J. Invest. Dermatol. |volume=131 |issue=1 |pages=67–73 |date=January 2011 |pmid=20739951 |pmc=3130508 |doi=10.1038/jid.2010.251 |url=}}</ref> | |||
===Case-fatality rate/Mortality rate=== | ===Case-fatality rate/Mortality rate=== | ||
Revision as of 15:10, 9 October 2018
|
Atopic dermatitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Atopic dermatitis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Atopic dermatitis epidemiology and demographics |
|
Risk calculators and risk factors forAtopic dermatitis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
It now affects 10-20% of children and 1-3% of adults in industrialized countries, and its prevalence there has more than doubled in the past thirty years.[1]
Epidemiology and Demographics
Incidence
- The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
- In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
Prevalence
- The prevalence of atopic dermatitis is approximately 5,000-20,000 per 100,000 children worldwide.[2]
- The prevalence of atopic dermatitis is approximately 10700 per 100,000 children in United States.[3]
Case-fatality rate/Mortality rate
- In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
- The case-fatality rate/mortality rate of [disease name] is approximately [number range].
Age
- Patients of all age groups may develop [disease name].
- The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
- [Disease name] commonly affects individuals younger than/older than [number of years] years of age.
- [Chronic disease name] is usually first diagnosed among [age group].
- [Acute disease name] commonly affects [age group].
Race
- There is no racial predilection to [disease name].
- [Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
Gender
- [Disease name] affects men and women equally.
- [Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.
Region
- The majority of [disease name] cases are reported in [geographical region].
- [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
Developed Countries
Developing Countries
References
- ↑ Saito, Hirohisa. Much Atopy about the Skin: Genome-Wide Molecular Analysis of Atopic Eczema. International Archives of Allergy and Immunology 2005;137:319-325.
- ↑ Williams H, Robertson C, Stewart A, Aït-Khaled N, Anabwani G, Anderson R, Asher I, Beasley R, Björkstén B, Burr M, Clayton T, Crane J, Ellwood P, Keil U, Lai C, Mallol J, Martinez F, Mitchell E, Montefort S, Pearce N, Shah J, Sibbald B, Strachan D, von Mutius E, Weiland SK (January 1999). "Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood". J. Allergy Clin. Immunol. 103 (1 Pt 1): 125–38. PMID 9893196.
- ↑ Shaw TE, Currie GP, Koudelka CW, Simpson EL (January 2011). "Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health". J. Invest. Dermatol. 131 (1): 67–73. doi:10.1038/jid.2010.251. PMC 3130508. PMID 20739951.